MicroNET-covered stent (CGuard) is a self-expandable 2nd-generation carotid dual-layer anti-embolic (“mesh”) stent with level-1 (randomized controlled trial) evidence for a profound reduction of peri-procedural cerebral embolism and elimination of lesion-related post-procedural embolism in carotid artery stenting (CAS) [1]. Clinical data demonstrate a minimized risk of 30-day death/stroke/myocardial infarction (≤ 1%) and optimal long-term outcomes with CGuard, in absence of device-related issues [2–6]. Today, competent CAS has a significant part in primary and secondary stroke prevention [7]. Also, evidence is increasing for an important role of the MicroNET-covered stent in improving the outcomes of emergency CAS in acute carotid-related strokes [8–10].
CGuard consists of a very widely open-cell (laser-cut) metallic frame (free cell area of ~22 mm²) that is wrapped by an outer, single-fiber knitted polyethylene terephthalate MicroNET adaptable sleeve (fiber thickness ~25 μm; cell size ~0.02–0.03 mm2; mesh fixation to the frame on stent edges [11, 12]); for a stent photograph see reference 13. CGuard combines properties of the most open-cell metallic stent frame (and thus very high conformability) with the smallest-cell anti-embolic layer [11, 12]. The MicroNET pore size is similar to that of embolic protection filters, resulting in a dense plaque coverage between the sparse struts, providing not only sequestration of the atherothrombotic plaque material but also a degree of sealing properties [13–17]. The MicroNET-covered stent shows no foreshortening or elongation and exhibits self-adaptability to the artery diameter (within the device nominal diameter; “SmartFit” characteristics) [11, 12]. The neuroprotective [1, 4, 14] stent has an increasing role in emergency management of carotid-related strokes [8–10]. Importantly, when properly implanted (post-dilatation embedded), the MicroNET-covered stent shows a normal healing profile and minimal in-stent restenosis (< 1%) [5, 6, 8, 17].
Embolic protection device use remains important in MicroNET-covered stent CAS because of the need to prevent cerebral embolism at procedural stages prior to protection by the MicroNET that is exerted only after the stent implantation and post-dilatation optimization [14]. Distal filters have several limitations relevant for cerebral safety of CAS [14, 18, 19]. Thus practical knowledge of how to effectively use proximal cerebral protection is crucial in today’s competent CAS [14, 20, 21]. For procedures at the level of carotid bifurcation, double-balloon systems, enabling transient endovascular exclusion of both the external (ECA) and common (CCA) carotid artery – and thus preventing any flow towards the brain in the internal carotid artery – are preferred [13, 14, 22] , as with a mono-balloon catheter the flow exclusion may be limited to CCA-only [13]. This, in some patients, can be insufficient for any effective cerebral protection because of the residual flow from the ECA to the ICA, towards the brain [13]. However, use of the double-balloon catheter [20] is not feasible in case of severe stenosis of the ECA ostium (Figures 1 A–C) and/or when the lesion involves distal CCA [13].
We present procedural imaging demonstrating how to resolve safely and effectively – using the endovascular route – an accidental implantation of the CGuard double-layered stent into the ECA (rather than ICA), covering the (diseased) ICA ostium with the MicroNET and strut structure; this occurred in CAS employing a mono-balloon catheter with transient flow reversal for cerebral protection (Figures 1 A–R). 5-year follow-up showed a maintained excellent anatomic result (Figures 1 S-T) in the context of uneventful clinical follow-up.
In conclusion, with mono-balloon use for proximal protection in CAS/eCAS, landmark separation of the ICA and ECA is critical to avoid accidental stent placement in ECA. We show that inadvertent placement of the dual-layer MicroNET-covered stent can be resolved, using the endovascular route (same, continued procedure), by (1) crossing the MicroNET and stent strut frame and making a step-wise gradual opening onto the ICA, followed by (2) placement and optimization of another MicroNET-covered stent (appropriately positioned in the ICA; “Y” technique). This endovascular resolution was safe and effective, with an optimal clinical and anatomic result at long-term. Today, ensured separation of ICA from the ECA under mono-balloon catheter proximal cerebral protection can be practiced – along with neurovascular interventions – in a novel human stroke model [23].